MYCOBACTERIA CORYNEBACTERIA LEGIONELLA Faculty: Dr. Alvin Fox 1
KEYWORDS • • • • • • • • • • • • • • • •
Acid Fast Tuberculosis (TB) M. tuberculosis (MDR, XDR) M. avium - M. intracellulare complex M. bovis M. leprae Tubercle PPD Tuberculin Mycobactin Cord factor BCG Leprosy (Hansen's Disease) AIDS and TB Runyon groups Mycolic acids
• • • • • • • • • • • • •
Diphtheria C. diphtheriae Loeffler's agar Tellurite agar Metachromatic bodies Diphtheria toxin Schick test Diphtheroids Legionella pneumophila Legionnaires disease Pontiac fever Legionella micdadei Pittsburg pneumonia
2
Mycobacterium tuberculosis obligate aerobe acid-fast rods
3
Tuberculosis (TB, consumption) • M. tuberculosis • major human disease – healthy people • problems – association with AIDS – multiple drug-resistance
4
M. avium- M. intracellulare complex (M. avium) • non-AIDS – infection almost never • AIDS – major bacterial opportunist • multiple drug-resistance 5
M. bovis • spread from cattle • infected cattle are culled – positive skin test • rarely seen in US
6
M. leprae • • •
leprosy major disease of third world rare in US
7
Transmission -tuberculosis • M. tuberculosis causes disease – healthy individuals
• transmitted man-man • airborne droplets
8
Pathogenesis of tuberculosis • infects lung • distributed within macrophages • facultative intracellular pathogen – inhibits phagosome-lysosome fusion
9
Cell-mediated immunity -tuberculosis • infiltration – macrophages – lymphocytes
• •
granulomas tubercules 10
Laboratory diagnosis tuberculosis • skin testing – delayed hypersensitivity – tuberculin – protein purified derivative, PPD
• X-ray
11
Positive skin test -tuberculosis • indicates exposure to organism • does not indicate active disease
12
Other minor pathogenesis factors tuberculosis • mycobactin – siderophore • cord factor – damages mitochondria
13
Laboratory diagnosis M. tuberculosis • acid fast bacteria – sputum
14
Laboratory diagnosis M. tuberculosis (culture) • grows very slowly – two weeks or longer – non-pigmented colonies – niacin production
*differentiates from other mycobacteria
15
Tuberculosis • polymerase chain amplification – rapid diagnosis
16
Antibotic treatment tuberculosis • • •
extensive time periods (e.g. 9 months) organism grows slowly, or dormant two or more antibiotics – e.g. rifampin and isoniazid – resistance minimized
17
Tuberculosis and Drug resistance • Multiple drug resistant (MDR) – resistant to first line drugs • Extremely drug resistant (XDR) – Resistant to some of the second line drugs – Nearly un-treatable 18
Vaccination • BCG vaccine – an attenuated strain of M. bovis – not effective • in US, – incidence is low – vaccination not practiced – immunization interferes with diagnosis
19
Mycobacterium leprae
20
Leprosy (Hansen's Disease) • M. leprae – causative agent
• chronic disease – disfigurement
• rarely seen in the U.S. • common in third world • millions of cases
• infects the skin – low temperature
21
ulcers, resorption of bone worsened from careless use of hands (nerve damage)
22
Leprosy • tuberculoid • few organisms • active cell-mediated immunity • lepromatous • many organisms • immunosuppression
23
Production of M. leprae antigens and pathogenesis studies • in vitro – unculturable • in vivo growth – low temperature – armadillo – mouse footpad
24
Leprosy • lepromin – skin testing • acid-fast stains – skin biopsies • clinical picture
25
Other mycobacterial species (including M. avium) • infect immunocompromised host • not transmitted man-man, healthy people • M. avium – common • Other species - rare
26
Mycobacterial diseases • tuberculosis-like • leprosy-like
27
Mycobacteria and AIDS • M. avium is much less virulent than M. tuberculosis – does not infect healthy people – infects AIDS patients • M. avium infects – when CD4 (helper T cell) count greatly decreased • M. tuberculosis infection – infects healthy people – infects AIDS patients * earlier stage of disease * more systemic 28
Clinical features with AIDS • systemic disease (versus pulmonary) – greater in AIDS • lesions often lepromatous
29
Antibiotic therapy
• selected primarily for M. tuberculosis • if M. avium involved other antibiotics included
30
Other species • pigmented or not • pigmentation – in the light – in the dark • growth – fast – slow
31
Mycobacterial species identification • • •
cellular fatty acid profiles mycolic acid profiles genetic markers
32
• mycobacteria – longest chain length – strongly acid fast • – –
Mycolic acids
nocardia intermediate chain length weakly acid fast
• corynebacteria • shortest chain length – not acid fast
33
Corynebacterium diphtheriae
Gram positive strict aerobe pleomorphic (e.g. club-shaped) 34
Diphtheria • infection – upper respiratory tract (pharynx) – pseudomembrane – chocking – bacteria do not spread systemically
. 35
This child has diphtheria resulting in a thick gray coating over back of throat. This coating can eventually expand down through airway and, if not treated, the child could die from suffocation CDC
36
Diptheria toxin • spreads • systemic and fatal injury
37
Diphtheria toxin • B binds to host cell • A inhibits protein synthesis • ADP-ribose moiety (NADH) attaches – elongation factor 2 inhibited
38
Treatment • anti-toxin • antibiotic
39
Immunization against diphtheria (infant) • disease vanished in US – without immunization will return • toxoid (+ pertussis and tetanus) DPT • neutralizing antibodies • colonization not inhibited – found in normal flora 40
Testing immunity • Schick skin test -toxin
41
Diphtheria toxin • coded by bacteriophage tox gene – – –
not synthesized if iron present iron-repressor complex forms inhibits expression of tox gene
42
Identification - C. diphtheriae • growth Loeffler's medium • stain for polyphosphate granules • metachromatic – polyphosphate granules (pink) cell (blue) • tellurite agar • reduction by bacteria • tellurium precipitation • black colonies 43
Identification – Exotoxin production • in vivo • in vitro
44
C. diphtheriae should not be confused with: • diphtheroids – other corynebacteria – propionibacteria
45
Legionella pneumophila •Gram negative rod •Stains poorly
46
Legionella pneumophila • Legionnaire's disease – pneumonia – fatal if not treated – erythromycin • Pontiac fever – flu-like – milder – self-limiting – myalgia (muscle pain) – no pneumonia 47
Transmission • contaminated air – infected water supply
• not spread person-person
48
Legionella pneumophia • environmental reservoir – pools of stagnant water – hot water towers – air conditioning systems – intracellular growth, protozoa • facultative intracellular pathogen – humans
49
Legionnaires disease • small epidemics – healthy people • more frequently – sick or elderly – hospitals – immunocompromised 50
Identifcation of Legionella • no growth conventional agar – e.g. sheep blood agar • media must contain – iron – cysteine – e.g. charcoal yeast extract agar • isolation clinical specimens – poor
51
Legionellae • Legionella pneumophila – several serogroups – most infections, serogroup 1 • Legionella micdadei – Pittsburg pneumonia • Other Legionella – occasional disease – legionellosis 52
Identification of Legionella • fatty acid profiling • DNA-DNA hybridization • 16S rRNA sequence • antigen detection in urine • serology 53